- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 17-06-2026: Press Release
17-06-2026 | 05:05 pm
17-06-2026 | 05:05 pm
Lupin launched Azilsartan Medoxomil Tablets in the US, a hypertension generic. As first-to-file, it secured 180-day exclusivity. The reference product's estimated annual US sales were USD 53.5 million, indicating significant market opportunity.
No comments yet. Be the first to comment!